Article

BlephEx introduces medical device for blepharitis

A novel medical device from BlephEx allows physicians to perform a painless, in-office procedure to treat blepharitis-thus relieving patients from the chronic and irritating symptoms of inflammatory lid disease and dry eye.

BlephEx introduces medical device for blepharitis

 

Chicago-A novel medical device from BlephEx allows physicians to perform a painless, in-office procedure to treat blepharitis-thus relieving patients from the chronic and irritating symptoms of inflammatory lid disease and dry eye.

The BlephEx handpiece enables eye-care professionals to reduce scurf, bacterial debris, and the biofilm-thereby improving the overall health of the eyelid, said James Rynerson, MD, president and chief executive officer of BlephEx LLC.

In case you missed it: LASIK Quality of Life Collaboration Project characterizes benefit, burden

The device can save patients hundreds of dollars in the costs of prescription drops, home scrubs, humidity goggles, and artificial tears that mask the symptoms but do not eliminate the cause, according to the company.

Dr. Rynerson explained that the medical device removes the biofilm, completely clearing the lids of the inflammatory exotoxins that accumulate along the margins.

 

BlephEx features a medical grade disposable, micro-sponge that spins along the edge of eyelids and lashes, exfoliating the eyelids. A numbing drop is placed in each eye prior to treatment for increased comfort. Following the 6- to 8-minute, well-tolerated procedure, patients often report a near immediate resolution of the chronic eye irritation associated with blepharitis and an eventual resumption of normal tear production.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.